STAT+: Former Stanford president releases emails to rebut fraud and cover-up allegations in new book
Marc Tessier-Lavigne released new details from his research and travel in an attempt to refute allegations in a new…
Read at source →Source
STAT News
Medicine, biotech, and health policy
Health · 280 articles · page 3 of 8 · fetched 22 minutes ago
STAT+: CMS plans launch event for ACCESS, the Medicare chronic care pilot
In this edition of STAT Health Tech: CMS plans a launch event for Medicare chronic care pilot, and what the Meta…
Read at source →
STAT+: Hospitals plot their response to funding cuts
Hospital prep a lobbying push, RFK Jr. faces more bad news on measles, and the cancer drug that helped Ben Sasse gets…
Read at source →
AdSponsoredSiguimi
Pure chronological social — no algorithm
See who you follow, newest first. Free to join. Posts that stay visible — not buried by an algo.
Join siguimi.com →
What’s in Merck and Moderna’s cancer vaccine algorithm?
A heart drug failure, RevMed's pancreatic cancer drug approved, and more biotech news from The Readout
Read at source →
STAT+: Pharmalittle: We’re reading about a pancreatic cancer drug approval, a Trump deal with biotechs, and more
The FDA approved a life-extending treatment for advanced pancreatic cancer from Revolution Medicines that is the first…
Read at source →
RFK Jr. said a Samoa trip had nothing to do with vaccines. New documents refute that
Health secretary Robert F. Kennedy Jr. said a Samoa trip had nothing to do with vaccines. New documents obtained by The…
Read at source →
Decoding DEA action on kratom-related substances
RFK Jr. downplays measles threat, FDA approves pancreatic drug, and more health news from Morning Rounds
Read at source →
STAT+: Cassidy criticizes FDA oversight of abortion pill manufacturers in new report
The report raises a high-profile issue for Heidi Overton as she faces confirmation as FDA commissioner.
Read at source →
STAT+: Alnylam’s heart drug troubles take center stage at a cardiology conference
The European Society of Cardiology Congress that kicks off Friday in Munich will be a consequential meeting for Alnylam…
Read at source →
STAT+: The mystery of Moderna’s magic algorithm
A personalized cancer vaccine developed by Moderna and Merck may be a triumph of immunology and cancer biology. It…
Read at source →
A state gave sheriffs 20% of its opioid settlement cash. We followed the money
KFF Health News examines how sheriffs are spending opioid settlement money, finds they're spending millions on police…
Read at source →
Hospitals are plotting a long-shot push to roll back $1 trillion in Medicaid cuts
Inside health systems' efforts to mitigate massive funding cuts.
Read at source →
Opinion: STAT+: A bill is supposed to protect U.S. biotech from Chinese competition. But there’s a loophole
“Biotech industry leaders must forge a new geographic path before heavy-handed legislation forces the issue,” write…
Read at source →
Opinion: I studied Reddit forums on menopause — and found what doctors are missing
“The menopause symptoms women are discussing online should become the questions researchers ask next,” writes…
Read at source →
Kennedy posts vaccine misinformation, spars on social media amid measles deaths
Kennedy has blamed others for declining vaccination rates, and downplayed the dangers of measles.
Read at source →
On the fence about a statin? In borderline cases, calcium scans could be a tiebreaker
The increasingly popular coronary artery calcium scan is helpful in guiding statin use in only a small share of cases,…
Read at source →
STAT+: FDA approves new pancreatic cancer drug expected to usher in new era of treatment
The FDA has approved a life-extending treatment for advanced pancreatic cancer — the first such therapy to attack a…
Read at source →
STAT+: Key data on a new class of cardio drugs are coming
GSK's shingles vaccine, new financial investment in women's health, and more biotech news from The Readout
Read at source →
STAT+: AI biotech Insitro’s Daphne Koller on how to speed up clinical trials
In this edition of STAT's AI Prognosis: A conversation with Insitro CEO Daphne Koller on artificial intelligence in…
Read at source →
Even at big companies, health care costs are increasing
Two U.S. measles deaths, the profit motive for women's health, and more Morning Rounds news today
Read at source →STAT+: Pharmalittle: We’re reading about a GSK shingles shot, U.S. employers dropping GLP-1 coverage, and more
About 14% of employers in the U.S. have already or plan to drop coverage of GLP-1 drugs in 2027, as companies see…
Read at source →
Newer shingles vaccine linked to lower heart disease risk, ‘natural experiment’ shows
Oxford researchers call shingles shot first vaccine protecting both heart and brain. Lower heart disease risk follows…
Read at source →
STAT+: New treatments for common cardiovascular risk factor near the market, with billions at stake
High cholesterol can be managed with medicine, but high Lp(a) levels, another common cardiovascular risk, cannot.…
Read at source →
STAT+: When it comes to women’s health, money talks
Women's health experts suggest a 'reverse pitch' approach to endometriosis, osteoporosis, and autoimmune treatments,…
Read at source →
Opinion: Many post-Dobbs abortion fears have not come to pass. What does that mean for advocates?
Opposition to abortion restrictions should focus on values, not statistics, writes David N. Hackney, author of…
Read at source →
Opinion: Medical aid in dying and the burden of choosing to live
“Once medical aid in dying becomes available, the status quo changes,” writes Monika Piotrowska.
Read at source →
STAT+: Sword Health to acquire Headspace, according to filing
Sword Health, a digital health company, plans to acquire mental health services provider Headspace, according to a…
Read at source →
Pennsylvania reports first 2 measles deaths in the U.S. this year, both people unvaccinated
Two unvaccinated Pennsylvania residents have died from measles, state health officials said Tuesday, the first…
Read at source →
STAT+: How Trump’s funding cuts are reshaping the health system
STAT examines Republicans’ health care funding cuts, mRNA science defeats politics, and Medicaid tries out a new way to…
Read at source →
STAT+: After a years-long slump, Massachusetts biopharma sector has come roaring back in 2026
The number of people working in Massachusetts’ biotech sector fell last year, for the first time since at least 2002.…
Read at source →
STAT+: FDA promises new AI guidance, and what happened at Epic’s UGM
In this edition of STAT Health Tech: FDA's plans for regulating generative AI-powered devices, and updates from EPIC's…
Read at source →
STAT+: Turkish antitrust authorities probe Teva for allegedly gaming the patent system, disparaging rival drugs
Turkish regulators are investigating Teva Pharmaceutical for allegedly manipulating the patent system and disparaging…
Read at source →STAT+: Pharmalittle: We’re reading about RFK Jr. vaccine disclosures, a Merck loss over Medicare prices, and more
Democratic senators said RFK Jr.'s recent explanation of how he disposed of a financial stake in Gardasil litigation…
Read at source →
CDC releases latest life expectancy data
Deleted public comments on White House proposals, how Trump cuts are reshaping rural health care, and more Morning…
Read at source →
STAT+: Comments on OMB research rule mysteriously removed from federal website
Some comments on a proposed OMB research rule have been mysteriously removed from a public-facing government webpage.
Read at source →
STAT+: AI is good at catching drug theft at hospitals, but only when humans do their part
New AI technology can help hospitals prevent controlled substances from being stolen, or abused by staff, but those…
Read at source →